1.
Davidson L, van den Reek JM, van Hunsel F, de Jong EM, Kullberg BJ. Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center. Acta Derm Venereol [Internet]. 2022 Feb. 11 [cited 2024 May 13];102:adv00648. Available from: https://medicaljournalssweden.se/actadv/article/view/175